Gary Price

12.1k total citations · 3 hit papers
92 papers, 5.3k citations indexed

About

Gary Price is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gary Price has authored 92 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cellular and Molecular Neuroscience, 36 papers in Molecular Biology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gary Price's work include Neurotransmitter Receptor Influence on Behavior (29 papers), Receptor Mechanisms and Signaling (27 papers) and Neuroscience and Neuropharmacology Research (24 papers). Gary Price is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (29 papers), Receptor Mechanisms and Signaling (27 papers) and Neuroscience and Neuropharmacology Research (24 papers). Gary Price collaborates with scholars based in United Kingdom, United States and Italy. Gary Price's co-authors include Derek N. Middlemiss, Warren D. Hirst, Melanie Calvert, Eileen M. Joyce, R. Myers, Claire Roberts, Graham J. Riley, Steven M. Bromidge, Marcus Rattray and Olalekan Lee Aiyegbusi and has published in prestigious journals such as Journal of Neuroscience, Gastroenterology and NeuroImage.

In The Last Decade

Gary Price

90 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The peripheral benzodiazepine binding site in the brain in multiple sclerosis

2000 546 citations Gary Price, R. Myers et al. profile →
Symptoms, complications and management of long COVID: a review

2021 543 citations Olalekan Lee Aiyegbusi, Sarah Hughes et al. Journal of the Royal Society of Medicine profile →
Maximising the impact of patient reported outcome assessment for patients and society

2019 199 citations Melanie Calvert, Gary Price et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Price United Kingdom	40	2.1k	1.7k	842	786	639	92	5.3k
Nigel Williams United Kingdom	49	1.4k 0.7×	2.9k 1.7×	944 1.1×	1.5k 1.9×	1.2k 1.9×	246	8.3k
Linda Chang United States	44	1.8k 0.8×	765 0.5×	673 0.8×	763 1.0×	1.8k 2.8×	88	6.4k
Jonas Hannestad United States	34	1.5k 0.7×	875 0.5×	403 0.5×	933 1.2×	608 1.0×	73	4.9k
Robert H. Lipsky United States	44	2.5k 1.2×	2.6k 1.5×	689 0.8×	962 1.2×	970 1.5×	112	8.1k
Dinko Franceschi United States	27	2.5k 1.2×	732 0.4×	454 0.5×	1.1k 1.4×	1.3k 2.0×	74	5.0k
Jody Tanabe United States	40	1.1k 0.5×	840 0.5×	733 0.9×	753 1.0×	1.8k 2.8×	95	5.0k
Kelly Cosgrove United States	36	1.8k 0.8×	1.5k 0.9×	261 0.3×	398 0.5×	835 1.3×	142	5.3k
Achim Berthele Germany	45	1.4k 0.7×	1.3k 0.8×	2.1k 2.5×	668 0.8×	714 1.1×	178	7.7k
Nicole Baumann France	45	1.9k 0.9×	3.2k 1.9×	1.0k 1.2×	419 0.5×	339 0.5×	239	8.4k
Mario Masellis Canada	46	1.1k 0.5×	916 0.5×	1.5k 1.7×	1.9k 2.4×	1.0k 1.6×	184	6.6k

Countries citing papers authored by Gary Price

Since Specialization

Citations

This map shows the geographic impact of Gary Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Price more than expected).

Fields of papers citing papers by Gary Price

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Price. The network helps show where Gary Price may publish in the future.

Co-authorship network of co-authors of Gary Price

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Price. A scholar is included among the top collaborators of Gary Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Price. Gary Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Farhan, Gary Price, Daniel L. Johnson, et al.. (2023). Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer. Biomedicines. 11(3). 648–648. 1 indexed citations

Bhome, Rohan, Andrew McWilliams, Gary Price, et al.. (2022). Metacognition in functional cognitive disorder. Brain Communications. 4(2). fcac041–fcac041. 34 indexed citations

Hughes, Sarah, Christel McMullan, Anna Rowe, et al.. (2022). Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study. BMJ Open. 12(9). e063199–e063199. 2 indexed citations

Rivera, Samantha Cruz, Richard Stephens, Rebecca Mercieca‐Bebber, et al.. (2021). ‘Give Us The Tools!’: development of knowledge transfer tools to support the involvement of patient partners in the development of clinical trial protocols with patient-reported outcomes (PROs), in accordance with SPIRIT-PRO Extension. BMJ Open. 11(6). e046450–e046450. 8 indexed citations

Aiyegbusi, Olalekan Lee, Sarah Hughes, Grace Turner, et al.. (2021). Symptoms, complications and management of long COVID: a review. Journal of the Royal Society of Medicine. 114(9). 428–442. 543 indexed citations breakdown →

Costello, Harry, et al.. (2021). How do ophthalmologists manage functional visual symptoms? A UK survey of ophthalmologists’ experience. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(4). 1307–1313. 7 indexed citations

Gutiérrez-Galve, Leticia, Claudia A. M. Gandini Wheeler‐Kingshott, Daniel R. Altmann, et al.. (2010). Changes in the Frontotemporal Cortex and Cognitive Correlates in First-Episode Psychosis. Biological Psychiatry. 68(1). 51–60. 66 indexed citations

Price, Gary, Mara Cercignani, Geoff J.M. Parker, et al.. (2007). White matter tracts in first-episode psychosis: A DTI tractography study of the uncinate fasciculus. NeuroImage. 39(3). 949–955. 96 indexed citations

Scott, Claire M., Ellen M. Soffin, Matthew Hill, et al.. (2006). SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue. European Journal of Pharmacology. 536(1-2). 54–61. 13 indexed citations

10.

Price, Gary, Mara Cercignani, Geoff J.M. Parker, et al.. (2006). Abnormal brain connectivity in first-episode psychosis: A diffusion MRI tractography study of the corpus callosum. NeuroImage. 35(2). 458–466. 101 indexed citations

11.

Price, Gary, et al.. (2003). The Invisible Web: Uncovering sources search engines can't see. Library trends. 52(2). 282–298. 15 indexed citations

12.

Thomas, David R., Sergio Melotto, Andrew D. Gribble, et al.. (2003). SB‐656104‐A, a novel selective 5‐HT₇ receptor antagonist, modulates REM sleep in rats. British Journal of Pharmacology. 139(4). 705–714. 101 indexed citations

13.

Watson, Jeannette M., C. Roberts, Claire M. Scott, et al.. (2001). SB‐272183, a selective 5‐HT_1A, 5‐HT_1B and 5‐HT_1D receptor antagonist in native tissue. British Journal of Pharmacology. 133(6). 797–806. 15 indexed citations

14.

Wood, Martyn, Simon Q.J. Rice, P. Punia, et al.. (2000). The human GABA_B1b and GABA_B2 heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen. British Journal of Pharmacology. 131(6). 1050–1054. 25 indexed citations

15.

Hagan, Jim J., Gary Price, Philip D. Jeffrey, et al.. (2000). Characterization of SB‐269970‐A, a selective 5‐HT₇ receptor antagonist. British Journal of Pharmacology. 130(3). 539–548. 254 indexed citations

16.

Hirst, Warren D., Gary Price, Marcus Rattray, & Graham P. Wilkin. (1998). Serotonin transporters in adult rat brain astrocytes revealed by [3H]5-HT uptake into glial plasmalemmal vesicles. Neurochemistry International. 33(1). 11–22. 63 indexed citations

17.

Hirst, Warren D., Gary Price, Marcus Rattray, & Graham P. Wilkin. (1997). Identification of 5‐hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes. British Journal of Pharmacology. 120(3). 509–515. 67 indexed citations

18.

Price, Gary. (1995). Meeting Highlights: 3rd IUPHAR Satellite Meeting on Serotonin July 30 - August 3 1994, Chicago, USA: Serotonin 94. Expert Opinion on Investigational Drugs. 4(1). 45–47. 1 indexed citations

19.

Price, Gary, C. Roberts, Jeanette Watson, et al.. (1995). Species differences in 5-HT autoreceptors. Behavioural Brain Research. 73(1-2). 79–82. 19 indexed citations

20.

Luthra, S. K., Claudio Pascali, Victor W. Pike, et al.. (1991). The radiosynthesis of [18F]PK 14105 as an alternative radioligand for peripheral benzodiazepine binding sites. Journal of Labelled Compounds and Radiopharmaceuticals. 30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact